查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1519778

2024-2032 年按产品、材料、用途、配销通路、最终用户和地区分類的注射器市场报告

Syringes Market Report by Product, Material, Usage, Distribution Channel, End User, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 148 Pages | 商品交期: 2-3个工作天内

价格

2023年全球注射器市场规模达196亿美元。政府机构鼓励个人快速、安全接种疫苗的有利政策是推动市场发展的因素之一。

注射器市场分析：

主要市场驱动因素：慢性病盛行率的上升主要支撑了市场。此外，由于接受手术介入的人数不断增加，人们越来越倾向于使用一次性注射器来输送麻醉剂，这也是另一个重要的生长诱导因素。

主要市场趋势：主要参与者日益关注高效的消毒手术，同时避免医疗保健从业者和患者感染，这是扩大市场的新兴趋势之一。除此之外，一次性医疗用品的广泛普及正在进一步积极影响市场。

竞争格局：全球市场上一些知名的公司包括 B. Braun Melsungen AG、Baxter International Inc.、Becton Dickinson and Company、Cardinal Health Inc.、Gerresheimer AG、Hindustan Syringes & Medical Devices Ltd.、Nipro Corporation、Pfizer Inc. . 、Retractable Technologies Inc.、Schott AG、Smiths Group plc、Terumo Corporation 和Thomas Scientific LLC 等。

地理趋势：由于政府机构在安全和感染控制方面采取了许多倡议，北美在市场上表现出明显的主导地位。此外，先进的製造流程将在预测期内继续推动区域市场的发展。

挑战与机会：阻碍​​市场的关键因素之一是与针刺伤相关的风险。然而，为医疗保健专业人员推出全面的培训计划，以确保正确的使用和处置做法，预计将在未来几年促进全球市场的发展。

注射器市场趋势：

对先进註射器的需求

提高注射器安全性和功能性的新颖进步的引入对注射器市场前景产生了积极影响。例如，2024 年3 月，自动失效和一次性注射器的领先製造商之一印度斯坦注射器和医疗器材(HMD) 推出了Dispojekt，这是一种本土一次性安全注射器，可最大程度地减少针刺伤害的情况。除此之外，2024年5月，总部位于德国的医疗保健和药品包装公司Gerresheimer宣布扩建墨西哥克雷塔罗工厂，以提高即用型（RTF）注射器的生产能力，从而满足市场需求在北美。此外，人们对家庭医疗保健的偏好转变，以及生物製剂的普及，也推动了市场的发展。例如，2024 年3 月，製药药物密封解决方案和输送系统提供者之一的肖特製药公司(SCHOTT Pharma) 在威尔逊建立了第一家美国工厂，生产预充式聚合物注射器，以满足mRNA 深冷储存和运输的需求。该工厂还可以进一步生产用于 GLP-1 疗法的玻璃预填充注射器，例如治疗糖尿病或肥胖症的疗法。

慢性病的盛行率

包括癌症、糖尿病、心血管疾病等在内的慢性疾病发生率不断上升，对透过注射器定期、精确给药的需求不断增加。欧洲毒品和药物成瘾监测中心 (EMCDDA) 和欧洲疾病预防和控制中心 (ECDC) 于 2023 年 11 月发布的报告评估了针头和注射器计划 (NSP) 等干预措施在预防感染方面的有效性。此外，胰岛素注射器在糖尿病日常管理中的广泛使用也提振了市场。例如，2023 年 11 月，泰尔茂印度公司推出了胰岛素注射器，这是一种为需要定期注射胰岛素的患者提供的无菌输送装置。它是 Terumo Medical Care Solutions 生命护理解决方案部门的新增成员。为此，特别设计了3斜面超锋利针头和高级硅胶表面，使注射器更加温和，让患者感觉更舒适。其独特的柱塞保持技术可避免浪费和溢出。此外，美国糖尿病协会估计，美国有数百万人需要注射胰岛素，从而推动了对可靠且用户友好的注射器的需求。

日益关注安全

人们越来越重视改善医疗机构内的感染控制，从而刺激了先进注射器技术的采用。例如，2024年5月，小分子、生物製剂和疫苗的无菌注射剂合约製造商之一的Grand River Aseptic Manufacturing (GRAM)扩大了注射器和药筒产能，为行业不断提升的生物製剂管道和增长提供更大的产能。除此之外，政府机构实施严格的法规，强制使用安全注射器以防止针刺伤，这进一步成为重要的成长诱导因素。例如，2024 年 3 月，美国食品药物管理局 (FDA) 建议美国医疗机构立即停止使用某些未经授权的中国製造塑胶注射器。这些建议不适用于预充式註射器、玻璃注射器或用于口服或局部用途的注射器。因此，领先的製造商正在透过推出重要的高品质医疗产品来做出回应，这将在未来几年继续提振市场。例如，2024年3月，医疗技术公司之一的BD（Becton，Dickinson and Company）提高了美国内布拉斯加州和康乃狄克州工厂的注射器国内生产，以满足客户需求。

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 资料来源
    • 主要资源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球注射器市场

  • 市场概况
  • 市场业绩
  • COVID-19 的影响
  • 市场预测

第 6 章：市场区隔：依产品

  • 普通注射器
    • 市场走向
    • 市场预测
  • 专用注射器
    • 市场走向
    • 关键环节
      • 胰岛素注射器
      • 结核菌素注射器
      • 过敏注射器
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 7 章：市场区隔：依材料

  • 玻璃注射器
    • 市场走向
    • 市场预测
  • 聚合物注射器
    • 市场走向
    • 市场预测

第 8 章：市场区隔：依用途

  • 一次性注射器
    • 市场走向
    • 关键环节
      • 传统注射器
      • 安全注射器
      • 预充式註射器
    • 市场预测
  • 可重复使用的注射器
    • 市场走向
    • 市场预测

第 9 章：市场区隔：按配销通路

  • 离线
    • 市场走向
    • 市场预测
  • 在线的
    • 市场走向
    • 市场预测

第 10 章：市场区隔：依最终用户

  • 医院和诊所
    • 市场走向
    • 市场预测
  • 诊断中心
    • 市场走向
    • 市场预测
  • 专科中心
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 11 章：市场区隔：按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场走向
    • 市场细分：按国家/地区
    • 市场预测

第 12 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 13 章：价值链分析

第 14 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 15 章：价格分析

第16章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • B. Braun Melsungen AG
    • Baxter International Inc.
    • Becton Dickinson and Company
    • Cardinal Health Inc.
    • Gerresheimer AG
    • Hindustan Syringes & Medical Devices Ltd.
    • Nipro Corporation
    • Pfizer Inc.
    • Retractable Technologies Inc.
    • Schott AG
    • Smiths Group plc
    • Terumo Corporation
    • Thomas Scientific LLC
Product Code: SR112024A5665

The global syringes market size reached US$ 19.6 Billion in 2023. Looking forward, the market is expected to reach US$ 37.4 Billion by 2032, exhibiting a growth rate (CAGR) of 7.29% during 2024-2032. Favorable policies by government bodies for encouraging the fast and safe vaccination of individuals are among the factors fueling the market.

Syringes Market Analysis:

Major Market Drivers: The rising prevalence of chronic diseases is primarily bolstering the market. Moreover, the growing preference for single-use syringes to deliver anesthetics, owing to the increasing number of individuals who are undergoing surgical interventions, is also acting as another significant growth-inducing factor.

Key Market Trends: The inflating focus of key players on efficient sterilizing surgery while avoiding infections among healthcare practitioners and patients is one of the emerging trends augmenting the market. Apart from this, the widespread popularity of disposable medical supplies is further positively influencing the market.

Competitive Landscape: Some of the prominent companies in the global market include B. Braun Melsungen AG, Baxter International Inc., Becton Dickinson and Company, Cardinal Health Inc., Gerresheimer AG, Hindustan Syringes & Medical Devices Ltd., Nipro Corporation, Pfizer Inc., Retractable Technologies Inc., Schott AG, Smiths Group plc, Terumo Corporation, and Thomas Scientific LLC, among many others.

Geographical Trends: North America exhibits a clear dominance in the market, owing to the introduction of numerous initiatives by government bodies for safety and infection control. Furthermore, advanced manufacturing processes will continue to fuel the regional market over the forecasted period.

Challenges and Opportunities: One of the key factors hindering the market is the risk associated with needlestick injuries. However, the launch of comprehensive training programs for healthcare professionals to ensure proper usage and disposal practices is expected to catalyze the global market in the coming years.

Syringes Market Trends:

Demand for Advanced Syringes

The introduction of novel advancements for enhancing the safety and functionality of syringes is positively influencing the syringes market outlook. For example, in March 2024, Hindustan Syringes and Medical Devices (HMD), one of the leading manufacturers of auto-disable and disposable syringes, introduced Dispojekt, an indigenous single-use safety syringe to minimize instances of needle stick injuries. Besides this, in May 2024, Gerresheimer, a healthcare and pharmaceutical packaging company based in Germany, announced the expansion of its Queretaro facility in Mexico to increase the production capacities for ready-to-fill (RTF) syringes, thereby catering to the market demand in North America. Additionally, the shifting preference towards home-based healthcare, along with the elevating popularity of biologics, is also propelling the market. For instance, in March 2024, SCHOTT Pharma, one of the pharmaceutical drug containment solutions and delivery systems providers, built its first U.S. facility in Wilson to manufacture pre-fillable polymer syringes required to meet the need for deep-cold storage and transportation of mRNA medications. The site can further produce glass pre-fillable syringes for GLP-1 therapies, such as those that treat diabetes or obesity.

Prevalence of Chronic Diseases

The growing incidences of chronic diseases, including cancer, diabetes, cardiovascular disorders, etc., are escalating the need for regular and precise medication delivery via syringes. The report published by the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) and the European Centre for Disease Prevention and Control (ECDC) in November 2023 assessed the effectiveness of interventions, including needle and syringe programs (NSPs), to prevent infections among individuals. Moreover, the widespread usage of insulin syringes for the daily management of diabetes is also bolstering the market. For instance, in November 2023, Terumo India launched an insulin syringe, a sterile delivery device for patients requiring regular insulin injections. It is the addition to the Life Care Solutions division of Terumo Medical Care Solutions. In line with this, specifically designed to have a 3-bevel super sharp needle with a high-grade silicone surface, the syringe is gentle and more comfortable for patients. Its unique feature with plunger retention technology avoids wastage and spillage. Furthermore, the American Diabetes Association estimated that millions of individuals in the U.S. require insulin injections, thereby driving the demand for reliable and user-friendly syringes.

Increasing Focus on Safety

There is a rising emphasis on improving infection control within healthcare settings, thereby stimulating the adoption of advanced syringe technologies. For example, in May 2024, Grand River Aseptic Manufacturing (GRAM), one of the sterile injectable contract manufacturers of small molecules, biologics, and vaccines, expanded its syringe and cartridge capacity to provide greater capacity for the industry's elevating biologics pipeline and the growth in advanced drug delivery systems for patient self-administration. Apart from this, the implementation of stringent regulations by government bodies that mandate the use of safety syringes to prevent needlestick injuries is further acting as a significant growth-inducing factor. For instance, in March 2024, the Food and Drug Administration (FDA) advised healthcare organizations in the U.S. to immediately transition away from using certain unauthorized plastic syringes made in China. The recommendations do not apply to pre-filled syringes, glass syringes, or syringes utilized for oral or topical purposes. Consequently, leading manufacturers are responding by introducing essential high-quality medical products, which will continue to bolster the market in the coming years. For example, in March 2024, BD (Becton, Dickinson and Company), one of the medical technology companies, elevated domestic manufacturing of syringes in Nebraska and Connecticut facilities, U.S., to cater to customer needs.

Global Syringes Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with the market forecast at the global, regional, and country levels for 2024-2032. Our report has categorized the market based on the product, material, usage, distribution channel, and end user.

Breakup by Product:

General Syringes

Specialized Syringes

Insulin Syringes

Tuberculin Syringes

Allergy Syringes

Others

Among these, general syringes currently exhibit a clear dominance in the market

The report has provided a detailed breakup and analysis of the market based on the product. This includes general syringes, specialized syringes (insulin syringes, tuberculin syringes, and allergy syringes), and others. According to the report, general syringes represented the largest market segmentation.

General syringes, essential tools in medical and healthcare settings, are continually evolving with advancements in technology and design aimed at improving safety, accuracy, and convenience. One of the notable launches is the Medtronic MiniMed 770G Insulin Pump System, which integrates advanced smart technology for precise insulin delivery, catering specifically to diabetes patients. General syringes improve user safety and reduce the risk of accidental injuries, thereby driving the segment's growth.

Breakup by Material:

Glass Syringes

Polymer Syringes

Currently, glass syringes hold the largest market share

The report has provided a detailed breakup and analysis of the market based on the material. This includes glass syringes and polymer syringes. According to the report, glass syringes represented the largest market segmentation.

Glass syringes are a crucial component in the medical field, valued for their durability, chemical resistance, and precise delivery capabilities. Unlike plastic syringes, they do not interact with the medications they contain, thereby making them ideal for administering highly reactive or sensitive drugs, such as biologics and certain vaccines. Their use is prominent in the pharmaceutical and biotechnology industries, where maintaining the integrity of the substance is paramount. In January 2024, Schreiner MediPharm, a Germany-based global provider of functional label solutions for the healthcare industry, developed barrier function labels that are generally designed to protect against oxygen ingress for drugs contained in COC syringes.

Breakup by Usage:

Disposable Syringes

Conventional Syringes

Safety Syringes

Prefilled Syringes

Reusable Syringes

Disposable syringes hold the largest share in the market

The report has provided a detailed breakup and analysis of the market based on the usage. This includes disposable syringes (conventional syringes, safety syringes, and prefilled syringes) and reusable syringes. According to the report, disposable syringes represented the largest market segmentation.

Disposable syringes have become an indispensable tool in modern healthcare due to their convenience, affordability, and ability to reduce the risk of cross-contamination and infection significantly. Designed for single use, these syringes are typically made from plastic and come pre-sterilized, ensuring a high standard of hygiene. Their widespread adoption has been driven by health initiatives aiming to combat the spread of infectious diseases. According to the report by IMARC, the global disposable syringes market size reached US$ 15.1 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 27.4 Billion by 2032, exhibiting a growth rate (CAGR) of 6.7% during 2024-2032.

Breakup by Distribution Channel:

Offline

Online

The report has provided a detailed breakup and analysis of the market based on the distribution channel. This includes offline and online.

The offline segment, which includes hospitals, clinics, and retail pharmacies, continues to dominate the market due to the immediate availability of products and the trust consumers place in physical purchases, especially for critical healthcare supplies. This traditional distribution method is bolstered by strong relationships between manufacturers and healthcare providers, ensuring a steady supply chain and reliable access to syringes. Conversely, the online segment is experiencing rapid growth, driven by the increasing adoption of e-commerce platforms in the healthcare sector. Online distribution offers significant advantages such as convenience, wider product availability, and competitive pricing, which are particularly appealing to individual consumers and smaller healthcare facilities. Major players in the market, like Becton Dickinson (BD) and Terumo, are leveraging digital platforms to expand their reach and enhance customer engagement.

Breakup by End User:

Hospitals and Clinics

Diagnostic Centers

Speciality Centers

Others

The report has provided a detailed breakup and analysis of the market based on the end user. This includes hospitals and clinics, diagnostic centers, speciality centers, and others.

Syringes play a critical role across various healthcare settings. In hospitals and clinics, they are indispensable for a wide range of procedures, from routine vaccinations and blood draws to administering medications and intravenous therapies. Their reliability and ease of use make them a staple in these high-demand environments. Diagnostic centers heavily rely on syringes for sample collection and diagnostic testing, ensuring accurate and sterile handling of specimens. Specialty centers, such as oncology and diabetes care facilities, utilize them for precise administration of treatments like chemotherapy and insulin, which require meticulous dosing and safety. Other settings, such as outpatient care centers and emergency medical services, depend on syringes for immediate, on-the-go medical interventions, highlighting their versatility and importance in diverse medical scenarios.

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America currently dominates the market

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

As per the syringes market overview, the rising prevalence of chronic diseases, increased vaccination efforts, and advancements in medical technology are acting as growth-inducing factors in North America. Moreover, in the United States, stringent safety regulations set by the Occupational Safety and Health Administration (OSHA) have led to the widespread adoption of safety-engineered syringes that are designed to minimize needlestick injuries and enhance user safety. Besides this, the American Diabetes Association estimated that millions of individuals in the U.S. require insulin injections, thereby escalating the use of reliable and user-friendly syringes. Furthermore, prominent players like Becton Dickinson (BD) and Novo Nordisk are leading the market with their advanced insulin delivery systems.

Competitive Landscape:

The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major market companies have also been provided. Some of the key players in the market include:

B. Braun Melsungen AG

Baxter International Inc.

Becton Dickinson and Company

Cardinal Health Inc.

Gerresheimer AG

Hindustan Syringes & Medical Devices Ltd.

Nipro Corporation

Pfizer Inc.

Retractable Technologies Inc.

Schott AG

Smiths Group plc

Terumo Corporation

Thomas Scientific LLC

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

Syringes Market Recent Developments:

May 2024: Gerresheimer, one of the healthcare and pharmaceutical packaging companies based in Germany, expanded its Queretaro capacity of ready-to-fill (RTF) syringes in Mexico.

March 2024: SCHOTT Pharma built its first U.S. facility to manufacture pre-fillable polymer syringes required to meet the need for deep-cold storage and transportation of mRNA medications.

March 2024: Hindustan Syringes and Medical Devices (HMD), one of the leading providers of auto-disable and disposable syringes, launched Dispojekt, an indigenous single-use safety syringe to minimize instances of needle stick injuries.

Key Questions Answered in This Report

  • 1. What was the size of the global syringes market in 2023?
  • 2. What is the expected growth rate of the global syringes market during 2024-2032?
  • 3. What are the key factors driving the global syringes market?
  • 4. What has been the impact of COVID-19 on the global syringes market?
  • 5. What is the breakup of the global syringes market based on the product?
  • 6. What is the breakup of the global syringes market based on the material?
  • 7. What is the breakup of the global syringes market based on usage?
  • 8. What are the key regions in the global syringes market?
  • 9. Who are the key players/companies in the global syringes market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Syringes Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 General Syringes
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Specialized Syringes
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Insulin Syringes
      • 6.2.2.2 Tuberculin Syringes
      • 6.2.2.3 Allergy Syringes
    • 6.2.3 Market Forecast
  • 6.3 Others
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Material

  • 7.1 Glass Syringes
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Polymer Syringes
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Usage

  • 8.1 Disposable Syringes
    • 8.1.1 Market Trends
    • 8.1.2 Key Segments
      • 8.1.2.1 Conventional Syringes
      • 8.1.2.2 Safety Syringes
      • 8.1.2.3 Prefilled Syringes
    • 8.1.3 Market Forecast
  • 8.2 Reusable Syringes
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by Distribution Channel

  • 9.1 Offline
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Online
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast

10 Market Breakup by End User

  • 10.1 Hospitals and Clinics
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Diagnostic Centers
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast
  • 10.3 Speciality Centers
    • 10.3.1 Market Trends
    • 10.3.2 Market Forecast
  • 10.4 Others
    • 10.4.1 Market Trends
    • 10.4.2 Market Forecast

11 Market Breakup by Region

  • 11.1 North America
    • 11.1.1 United States
      • 11.1.1.1 Market Trends
      • 11.1.1.2 Market Forecast
    • 11.1.2 Canada
      • 11.1.2.1 Market Trends
      • 11.1.2.2 Market Forecast
  • 11.2 Asia-Pacific
    • 11.2.1 China
      • 11.2.1.1 Market Trends
      • 11.2.1.2 Market Forecast
    • 11.2.2 Japan
      • 11.2.2.1 Market Trends
      • 11.2.2.2 Market Forecast
    • 11.2.3 India
      • 11.2.3.1 Market Trends
      • 11.2.3.2 Market Forecast
    • 11.2.4 South Korea
      • 11.2.4.1 Market Trends
      • 11.2.4.2 Market Forecast
    • 11.2.5 Australia
      • 11.2.5.1 Market Trends
      • 11.2.5.2 Market Forecast
    • 11.2.6 Indonesia
      • 11.2.6.1 Market Trends
      • 11.2.6.2 Market Forecast
    • 11.2.7 Others
      • 11.2.7.1 Market Trends
      • 11.2.7.2 Market Forecast
  • 11.3 Europe
    • 11.3.1 Germany
      • 11.3.1.1 Market Trends
      • 11.3.1.2 Market Forecast
    • 11.3.2 France
      • 11.3.2.1 Market Trends
      • 11.3.2.2 Market Forecast
    • 11.3.3 United Kingdom
      • 11.3.3.1 Market Trends
      • 11.3.3.2 Market Forecast
    • 11.3.4 Italy
      • 11.3.4.1 Market Trends
      • 11.3.4.2 Market Forecast
    • 11.3.5 Spain
      • 11.3.5.1 Market Trends
      • 11.3.5.2 Market Forecast
    • 11.3.6 Russia
      • 11.3.6.1 Market Trends
      • 11.3.6.2 Market Forecast
    • 11.3.7 Others
      • 11.3.7.1 Market Trends
      • 11.3.7.2 Market Forecast
  • 11.4 Latin America
    • 11.4.1 Brazil
      • 11.4.1.1 Market Trends
      • 11.4.1.2 Market Forecast
    • 11.4.2 Mexico
      • 11.4.2.1 Market Trends
      • 11.4.2.2 Market Forecast
    • 11.4.3 Others
      • 11.4.3.1 Market Trends
      • 11.4.3.2 Market Forecast
  • 11.5 Middle East and Africa
    • 11.5.1 Market Trends
    • 11.5.2 Market Breakup by Country
    • 11.5.3 Market Forecast

12 SWOT Analysis

  • 12.1 Overview
  • 12.2 Strengths
  • 12.3 Weaknesses
  • 12.4 Opportunities
  • 12.5 Threats

13 Value Chain Analysis

14 Porters Five Forces Analysis

  • 14.1 Overview
  • 14.2 Bargaining Power of Buyers
  • 14.3 Bargaining Power of Suppliers
  • 14.4 Degree of Competition
  • 14.5 Threat of New Entrants
  • 14.6 Threat of Substitutes

15 Price Analysis

16 Competitive Landscape

  • 16.1 Market Structure
  • 16.2 Key Players
  • 16.3 Profiles of Key Players
    • 16.3.1 B. Braun Melsungen AG
      • 16.3.1.1 Company Overview
      • 16.3.1.2 Product Portfolio
      • 16.3.1.3 SWOT Analysis
    • 16.3.2 Baxter International Inc.
      • 16.3.2.1 Company Overview
      • 16.3.2.2 Product Portfolio
      • 16.3.2.3 Financials
      • 16.3.2.4 SWOT Analysis
    • 16.3.3 Becton Dickinson and Company
      • 16.3.3.1 Company Overview
      • 16.3.3.2 Product Portfolio
      • 16.3.3.3 Financials
      • 16.3.3.4 SWOT Analysis
    • 16.3.4 Cardinal Health Inc.
      • 16.3.4.1 Company Overview
      • 16.3.4.2 Product Portfolio
      • 16.3.4.3 Financials
      • 16.3.4.4 SWOT Analysis
    • 16.3.5 Gerresheimer AG
      • 16.3.5.1 Company Overview
      • 16.3.5.2 Product Portfolio
      • 16.3.5.3 Financials
    • 16.3.6 Hindustan Syringes & Medical Devices Ltd.
      • 16.3.6.1 Company Overview
      • 16.3.6.2 Product Portfolio
    • 16.3.7 Nipro Corporation
      • 16.3.7.1 Company Overview
      • 16.3.7.2 Product Portfolio
      • 16.3.7.3 Financials
      • 16.3.7.4 SWOT Analysis
    • 16.3.8 Pfizer Inc.
      • 16.3.8.1 Company Overview
      • 16.3.8.2 Product Portfolio
      • 16.3.8.3 Financials
      • 16.3.8.4 SWOT Analysis
    • 16.3.9 Retractable Technologies Inc.
      • 16.3.9.1 Company Overview
      • 16.3.9.2 Product Portfolio
      • 16.3.9.3 Financials
    • 16.3.10 Schott AG
      • 16.3.10.1 Company Overview
      • 16.3.10.2 Product Portfolio
      • 16.3.10.3 SWOT Analysis
    • 16.3.11 Smiths Group plc
      • 16.3.11.1 Company Overview
      • 16.3.11.2 Product Portfolio
      • 16.3.11.3 Financials
      • 16.3.11.4 SWOT Analysis
    • 16.3.12 Terumo Corporation
      • 16.3.12.1 Company Overview
      • 16.3.12.2 Product Portfolio
      • 16.3.12.3 Financials
      • 16.3.12.4 SWOT Analysis
    • 16.3.13 Thomas Scientific LLC
      • 16.3.13.1 Company Overview
      • 16.3.13.2 Product Portfolio

List of Figures

  • Figure 1: Global: Syringes Market: Major Drivers and Challenges
  • Figure 2: Global: Syringes Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Syringes Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Syringes Market: Breakup by Product (in %), 2023
  • Figure 5: Global: Syringes Market: Breakup by Material (in %), 2023
  • Figure 6: Global: Syringes Market: Breakup by Usage (in %), 2023
  • Figure 7: Global: Syringes Market: Breakup by Distribution Channel (in %), 2023
  • Figure 8: Global: Syringes Market: Breakup by End User (in %), 2023
  • Figure 9: Global: Syringes Market: Breakup by Region (in %), 2023
  • Figure 10: Global: Syringes (General Syringes) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Syringes (General Syringes) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Syringes (Specialized Syringes) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Syringes (Specialized Syringes) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Syringes (Other Products) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Syringes (Other Products) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Syringes (Glass Syringes) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Syringes (Glass Syringes) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Syringes (Polymer Syringes) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Syringes (Polymer Syringes) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Syringes (Disposable Syringes) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Syringes (Disposable Syringes) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Syringes (Reusable Syringes) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Syringes (Reusable Syringes) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Syringes (Offline) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Syringes (Offline) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Syringes (Online) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Syringes (Online) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Global: Syringes (Hospitals and Clinics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Global: Syringes (Hospitals and Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Global: Syringes (Diagnostic Centers) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Global: Syringes (Diagnostic Centers) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: Global: Syringes (Speciality Centers) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: Global: Syringes (Speciality Centers) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: Global: Syringes (Other End Users) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: Global: Syringes (Other End Users) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: North America: Syringes Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: North America: Syringes Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: United States: Syringes Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: United States: Syringes Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: Canada: Syringes Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: Canada: Syringes Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: Asia-Pacific: Syringes Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: Asia-Pacific: Syringes Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: China: Syringes Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: China: Syringes Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: Japan: Syringes Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: Japan: Syringes Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: India: Syringes Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: India: Syringes Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: South Korea: Syringes Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: South Korea: Syringes Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: Australia: Syringes Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: Australia: Syringes Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: Indonesia: Syringes Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: Indonesia: Syringes Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: Others: Syringes Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: Others: Syringes Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: Europe: Syringes Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: Europe: Syringes Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: Germany: Syringes Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: Germany: Syringes Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: France: Syringes Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: France: Syringes Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: United Kingdom: Syringes Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: United Kingdom: Syringes Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Italy: Syringes Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Italy: Syringes Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Spain: Syringes Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Spain: Syringes Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Russia: Syringes Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Russia: Syringes Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Others: Syringes Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Others: Syringes Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Latin America: Syringes Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: Latin America: Syringes Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 76: Brazil: Syringes Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 77: Brazil: Syringes Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 78: Mexico: Syringes Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 79: Mexico: Syringes Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 80: Others: Syringes Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 81: Others: Syringes Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 82: Middle East and Africa: Syringes Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 83: Middle East and Africa: Syringes Market: Breakup by Country (in %), 2023
  • Figure 84: Middle East and Africa: Syringes Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 85: Global: Syringes Industry: SWOT Analysis
  • Figure 86: Global: Syringes Industry: Value Chain Analysis
  • Figure 87: Global: Syringes Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Syringes Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Syringes Market Forecast: Breakup by Product (in Million US$), 2024-2032
  • Table 3: Global: Syringes Market Forecast: Breakup by Material (in Million US$), 2024-2032
  • Table 4: Global: Syringes Market Forecast: Breakup by Usage (in Million US$), 2024-2032
  • Table 5: Global: Syringes Market Forecast: Breakup by Distribution Channel (in Million US$), 2024-2032
  • Table 6: Global: Syringes Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 7: Global: Syringes Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 8: Global: Syringes Market: Competitive Structure
  • Table 9: Global: Syringes Market: Key Players